Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stock
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
— | 6,478 Cr | — | 3.81 | 0.00 | — | — | 0.00 | ||
100.00 | 6,200 Cr | 7.20 | 0.81 | 13.73 | 15.17 | 10.50 | 5.56 | ||
130.00 | 5,378 Cr | 38.19 | 1.33 | 4.84 | 3.80 | 5.26 | 2.55 | ||
5453.00 | 5,239 Cr | 28.35 | 4.82 | 1.11 | 17.29 | 22.66 | 13.62 | ||
257.75 | 5,126 Cr | 25.15 | 6.87 | 0.00 | 27.33 | 34.46 | 24.90 | ||
1616.30 | 5,071 Cr | 31.51 | 5.88 | 1.06 | 17.73 | 24.14 | 15.77 | ||
451.95 | 3,786 Cr | 29.28 | 2.81 | 0.83 | 9.59 | 16.13 | 1.82 | ||
| Median: 7 Co. | — | 354.85 | 5,239 Cr | 28.82 | 3.81 | 1.06 | 16.23 | 19.39 | 5.56 |
Upcoming Result Date: May 12, 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
CARE Ratings Ltd (CARERATING) is currently trading at 1,662.30 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
CareEdge (CARE Ratings Limited) is an India‑based knowledge and analytics group that provides credit ratings, analytics, consulting and sustainability services; it is India’s second‑largest credit rating agency with a group of subsidiaries covering analytics, ESG ratings and global IFSC operations, serving corporates, financial institutions and international sovereign and debt issuers. Financial momentum is visible in Q3 and 9M FY26: consolidated revenue rose 16% in Q3 and 17% in 9M to Rs. 112.12 Cr and Rs. 342.40 Cr respectively, while consolidated PAT margin expanded to 32% for 9M FY26, reflecting disciplined cost management and broad‑based growth across ratings and non‑ratings businesses. Ratings remain the dominant revenue driver, contributing 89% of consolidated 9M FY26 revenue (Rs. 305.69 Cr), while the non‑ratings segment grew faster at 21% and now contributes 11% of consolidated revenue, indicating early diversification beyond traditional rating services towards analytics, advisory and ESG offerings. Strategic product and market expansion are evident: CareEdge launched CareEdge Global IFSC for global scale ratings, secured SEBI Category I license for CARE ESG Ratings, and commercialized EdgeAvira.ai, a Gen‑AI risk intelligence platform, all of which signal deliberate moves to expand addressable markets and monetize technology‑enabled services.
Over the past 52 weeks, CARE Ratings Ltd has traded between a low of ₹1,150.00 and a high of ₹1,964.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
CARE Ratings Ltd has a market capitalization of approximately 5,071.05. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
CARE Ratings Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 31.51 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 5,071.05 Cr, CARE Ratings Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
CARE Ratings Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of CARE Ratings Ltd is 31.51. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
CARE Ratings upgraded Shriram Finance to 'AAA' due to its improved financial and operational performance, significantly bolstered by the strategic ₹39,618 crore investment from Japan's MUFG Bank.
Bearish
2
Neutral
7
Bullish
5
Bearish
2
Neutral
7
Bullish
37
Bearish
0
Neutral
0
Bullish
32
CareEdge (CARE Ratings Limited) is an India‑based knowledge and analytics group that provides credit ratings, analytics, consulting and sustainability services; it is India’s second‑largest credit rating agency with a group of subsidiaries covering analytics, ESG ratings and global IFSC operations, serving corporates, financial institutions and international sovereign and debt issuers.
Financial momentum is visible in Q3 and 9M FY26: consolidated revenue rose 16% in Q3 and 17% in 9M to Rs. 112.12 Cr and Rs. 342.40 Cr respectively, while consolidated PAT margin expanded to 32% for 9M FY26, reflecting disciplined cost management and broad‑based growth across ratings and non‑ratings businesses.
Ratings remain the dominant revenue driver, contributing 89% of consolidated 9M FY26 revenue (Rs. 305.69 Cr), while the non‑ratings segment grew faster at 21% and now contributes 11% of consolidated revenue, indicating early diversification beyond traditional rating services towards analytics, advisory and ESG offerings.
Strategic product and market expansion are evident: CareEdge launched CareEdge Global IFSC for global scale ratings, secured SEBI Category I license for CARE ESG Ratings, and commercialized EdgeAvira.ai, a Gen‑AI risk intelligence platform, all of which signal deliberate moves to expand addressable markets and monetize technology‑enabled services.
Capital Markets
Ratings
5,071 Cr
Low Risk
31.5
42.5
1.6
5.9
1,964.80
1,150.00
Sales CAGR
Profit CAGR
ROE
ROCE
Regulatory approval
SEBI has authorised CARE Ratings Limited to provide Past Risk and Return Verification Agency (PaRRVA) services from May 4, 2026, after successful pilot completion (SEBI circular dated Apr 29, 2026).
Board Meeting
CARE Ratings will hold a Board meeting on 13 May 2026 to approve audited standalone and consolidated financial results for the quarter and FY ended 31 Mar 2026 and to consider recommending a final dividend; trading window remains closed.
Board Meeting - Results
CARE Ratings will hold a Board meeting on May 13, 2026 to consider and approve audited standalone & consolidated financial results for Q4 and FY ended Mar 31, 2026 and to consider recommending a final dividend, if any.
